33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
View analysts' price targets and recommendations, and compare them with competitors.
$49.00
Has upside compared to FLNC's downside of 20.84%.
Buy
Better than FLNC's analyst recommendation of Hold.
Analyze analyst forecasts for the company and compare them with competitors.
1.24B
The estimated revenue has increased from the previous period.
-788.81M
The estimated EBITDA has decreased from the previous period.
0.22
The estimated EPS has increased from the previous period.
118.22M
The estimated net income has increased from the previous period.
-887.36M
The estimated EBIT has decreased from the previous period.
1.39B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
9.54B
Revenue has decreased from the previous period.
50.16%
Revenue growth rate has decreased from the previous period.
-4.42B
EBITDA has increased from the previous period.
-46.37%
EBITDA margin has increased from the previous period.
-5.21B
EBIT has increased from the previous period.
-54.67%
EBIT margin has increased from the previous period.
791.05M
Depreciation has decreased from the previous period.
7.90B
Total cash has decreased from the previous period.
82.81%
Cash percentage has decreased from the previous period.
1.73B
Receivables have decreased from the previous period.
18.17%
Receivables percentage has decreased from the previous period.
474.93M
Inventories have decreased from the previous period.
4.98%
Inventory percentage has decreased from the previous period.
671.79M
Accounts payable has decreased from the previous period.
7.04%
Payables percentage has decreased from the previous period.
-481.52M
Capital expenditure has decreased from the previous period.
-5.05%
CapEx percentage has decreased from the previous period.
12.11%
WACC has increased from the previous period.
12.14%
Cost of equity has increased from the previous period.
4.08%
Cost of debt has decreased from the previous period.
1.71
Beta has increased from the previous period.
556.32M
Diluted shares outstanding has increased from the previous period.
80.28M
Total debt has decreased from the previous period.
25.31B
Total equity has increased from the previous period.
25.39B
Total capital has increased from the previous period.
0.32%
Debt weighting has decreased from the previous period.
99.68%
Equity weighting has increased from the previous period.
-5.21B
EBIAT has increased from the previous period.
-5.42B
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-54.65B
Terminal value has increased from the previous period.
-40.12B
Enterprise value has increased from the previous period.
-147.30M
Net debt has decreased from the previous period.
-39.98B
Equity value has increased from the previous period.
-71.86
Equity value per share has increased from the previous period.
